Why the study?
It remained controversial whether troponin measurement is a useful tool for detecting reversible myocardial ischemia.
Do cardiac troponin levels correlate with the severity of reversible myocardial ischemia on regadenoson SPECT MPI in high-risk patients presenting with anginal symptoms?
Do cardiac troponin levels correlate with the severity of reversible myocardial ischemia on regadenoson SPECT MPI in high-risk patients presenting with anginal symptoms?
In high-risk patients with reversible myocardial ischemia on regadenoson SPECT MPI, cTnT elevation significantly correlates with severe ischemia and ischemic EKG changes, while cTnI is more sensitive for mild ischemia.
Answers are grounded in this paper and cite their sources.
Troponin subtype elevations may differentiate ischemia severity in high-risk angina; leaves open added value beyond SPECT MPI.
Background: Cardiac troponins are the preferred biomarkers for the diagnosis of myocardial necrosis and are routinely used to diagnose acute coronary syndrome. However, the controversy still continues as to whether troponin measurement may be the useful tool for detecting reversible myocardial ischemia. Objectives: The study objectives were to quantitatively assess cardiac troponin levels in patients presenting with anginal chest pain or angina equivalents, correlate these levels with the severity of reversible myocardial ischemia on regadenoson SPECT MPI, and identify variables influencing troponin release in high-risk patients. Methods: We included all patients with anginal chest pain or angina equivalents who underwent regadenoson single-photon emission computed tomography myocardial perfusion imaging, commonly known as Lexiscan, with positive stress results, defined as reversible myocardial ischemia. Their corresponding cardiac troponin levels and stress imaging parameters were reviewed. Results: In total, 96 patients with objective evidence of myocardial ischemia on stress lexiscans were studied. The cardiac troponin I (cTnI) was above the detection level of ≥0.02 ng/mL in 38, out of 63 patients (60.3%) and the cardiac troponin T (cTnT) was above the detection level of ≥0.010 ng/mL in 20, out of 33 patients (60.6%) by the fourth-generation assays. The median elevation (25–75 th percentile) of cTnI was 0.10 ng/mL (0.07–0.22) and the median elevation (25–75 th percentile) of cTnT was 0.051 ng/mL (0.026–0.211). Majority of patients (63.5%) did not have any ischemic electrocardiogram (EKG) changes. There was a pronounced elevation of cTnI in mild reversible myocardial ischemia ( P > 0.05), and statistically significant elevation of cTnT in patients with ischemic EKG changes and severe myocardial ischemia on lexiscan ( P < 0.05). Conclusion: Lexiscan is sensitive in detecting patients with reversible myocardial ischemia, even in the absence of ischemic EKG changes or troponin elevations. Cardiac troponins have complementary roles with cTnI sensitive for mild and cTnT sensitive for severe myocardial ischemia, respectively.
No takes yet. Share an insight, caveat, or question.
Mohsin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: